background In Pakistan, the prevalence of diabetes (DM) among adults is 6.9% and expected to double by 2040. DM may facilitate transmission and halter the elimination of tuberculosis (TB). We aimed to determine the prevalence of DM among patients with TB in Pakistan, and to investigate anthropometric biochemical and haemodynamic associations between TB patients with and without DM.
Introduction
Worldwide, 15% of all tuberculosis (TB) cases are estimated to be attributable to diabetes (DM). DM patients have an increased risk of developing TB and also experience worse outcome than those without DM [1] [2] [3] [4] . Furthermore, the relationship between the two diseases is bidirectional as TB affects the DM status by causing hyperglycaemia [5, 6] . TB remains a major public health problem in many low-and middle-income countries including Pakistan, where almost 50 000 persons die of the infection each year. The International Diabetes Federation has estimated that in 2015, 415 million people were living with DM worldwide, and in 2040, this figure is expected to increase to 642 million, with developing countries accounting for 80% of new cases [7] . Thus, DM is no longer a condition restricted to high-income countries, but is rapidly increasing in developing countries, affecting all levels of society in both urban and rural areas [8, 9] . Pakistan is among the top ten countries experiencing a disturbing rise of DM. A study from India estimated that DM is associated with new smear-positive TB in 20% or 116 000 cases; projected to Pakistan, this translates to 90 000 cases each year [10, 11] . Thus, in countries where both diseases are epidemic, the implications of their convergence become apparent.
The prevalence of DM among patients with TB varies from 4 to 40% depending on factors such as study site and methods. However, only one small study (n = 158) from Pakistan has been carried out showing a proportion of known DM of~26% and screen-detected DM of~6% [12] . The aim of our study was to assess the prevalence of DM among patients with TB in Pakistan, and to describe whether DM patients with TB exhibit anthropometric, biochemical and haemodynamic differences depending on their DM status, that is screen-detected DM (SDM) and known DM (KDM), compared with non-DM TB.
Methods

Study site
Gulab Devi Chest Hospital (GDCH), where the study took place, is located in Lahore, the provincial capital of Punjab, Pakistan. Punjab is divided into 36 districts with Lahore located in the east-central region near the Indian border ( Figure 1 ) [13] . Lahore is an urban megacity with an estimated 10 million inhabitants [14] . GDCH specialises in treatment of respiratory diseases, in particular TB, and is a semi-private tertiary hospital serving approximately 500 000 inhabitants in its catchment area. GDCH offers free TB treatment using directly observed treatment, short course (DOTS) to indigent patients. TB suspects are self-referred or referred from local TB clinics and come from all over Pakistan, although the majority are from Punjab. Each year, more than 15 000 TB cases (all types) are diagnosed at GDCH, of which approximately 50% are referred to their nearest TB clinic for continuation of DOTS.
Study methods
A cross-sectional study was conducted from May 2014 to September 2015. Newly diagnosed sputum smear-positive TB patients ≥25 years of age who had not initiated DOTS were invited to participate in the study. Smearnegative patients, pregnant women and patients with known type 1 DM were excluded from the study. Other exclusion criteria were concomitant immunocompromising disease or treatment. Trained hospital staff informed the patients about the study, information leaflets were handed out and consent was obtained in writing, or as a thumbprint in case of illiteracy. Ethics approval was obtained from the National Bioethics Committee, Pakistan.
At GDCH, TB is diagnosed according to the national guidelines for control of TB in Pakistan [15] . All TB suspects deliver two sputum samples (one at consultation and one next early morning) for microscopy of ZiehlNeelsen (ZN)-stained smears. Smears are graded according to the number of acid-fast bacilli (AFB) as negative (no AFB) or positive: scanty (1-9 AFB in 100 fields), 1+ (10-99 AFB in 100 fields), 2+ (1-10 AFB pr. field in 50 fields) or 3+ (>10 AFB pr. field in >20 fields). Furthermore, all patients underwent a chest X-ray.
Glycosylated haemoglobin (HbA1c, %, mmol/mol) was measured in the entire study population using an Afinion AS100 Analyzer (Alere-Axis Shield PoC, Norway). This analyser determines the HbA1c by an automated boronate affinity assay that minimises interference from other haemoglobin variants. Diagnosis of DM was based on previous history of DM or WHO criteria for the classification of DM, according to which values of HbA1c ≥ 6.5%/48.0 mmol/mol are diagnostic for DM [16] . The prevalence of SDM and KDM was calculated directly from our study data. Additional yield of new DM cases was obtained by calculating the proportion of SDM among the total number of DM cases (SDM/ (SDM + KDM). Number needed to screen was calculated from the following formula: total number of TB cases -KDM/SDM.
Haemoglobin (g/dl) was measured using Hemocue 301 ( € Angelholm, Sweden) and WHO reference values used: for men, normal ≥13.0, mild anaemia 11.0-12.9, moderate anaemia 8.0-10.9, severe anaemia <7.9 g/dl; for women, normal ≥12.0, mild anaemia 11.0-11.9, moderate anaemia 8.0-10.9, severe anaemia <7.9 g/dl. HIV testing was performed using a rapid test (Fastep HIV 1/2; Polymed Theraputics, Inc., Houston, USA). Participants with a positive HIV test were further tested with ELISA, excluded from the study and referred for further care and examination at the nearest HIV clinic.
Anthropometric measurements (weight, height, waist circumference (WC) and hip circumference (HC)), blood pressure and pulse rate were measured as recommended in the WHO STEPS Surveillance guide [17] . Weight, height, WC and HC were measured with the participants barefooted and lightly clothed. A portable electronic weight scale (Beurer Medical, Ulm, Germany) and a conventional stadiometer were used. WC was measured at the mid-point between the lower margin of the last palpable rib and the top of the iliac crest. Hip circumference measurement was taken around the widest portion of the buttocks. Body mass index (BMI) (kg/m 2 ) and waist-hip ratio (WHR) were calculated. BMI and WC cut-offs were based on WHO guidelines for South Asian populations, where recommendations are as follows: underweight, 16-18.4, normal, 18.5-22.9, overweight 23-24.9, obese, ≥25 (kg/m 2 ). Abdominal obesity was categorised as WC ≥ 90 cm (men) and ≥80 cm (women) [18, 19] . Blood pressure (mmHg) and pulse rate (PR, beats/min) measurements (OMRON, HEM-7321-E, Kyoto, Japan) were repeated three times in the right upper arm of the participant with intervals of 5 min after having been seated in an upright position for at least 15 min. Mean blood pressure and PR were derived from the two last measurements. Auricular temperature was measured with a digital ear thermometer (Beurer, Germany).
A structured questionnaire was administered to obtain information regarding socio-demographics and lifestyle risk factors such as smoking, educational level and occupation. Information on TB and DM symptoms, treatment as well as family history was also recorded.
Statistics
Data were analysed using Stata IC 13 (Stat Corp., Texas, USA). Participants with missing HbA1c and anthropometric values were excluded from the analysis. As we did not find a difference in results between nonparametric and parametric tests, between-group comparison of TB patients with and without DM was performed using a ttest on both skewed and normally distributed continuous variables (Table 1) . We further explored differences between the three groups (TB patients without DM, SDM and KDM) by one-way variance analysis. Chisquare test was used for categorical variables. Regression analyses were used to explore associations between continuous variables. Logistic regression was performed to examine associations between variables and the three groups (TB patients without DM as reference) and to calculate odds ratios (OR) ( Table 2) . Variables for the multivariate model were pre-specified based on plausibility; variables with P-values of <0.1 in univariate analysis were used for analyses. For all other analyses, P < 0.05 was regarded as level of significance.
Results
During our study period, 5306 smear-positive TB patients ≥25 years of age were diagnosed at GDCH. We excluded 2279 participants not fulfilling the study inclusion criteria (critically ill patients with TB, pregnant women, type 1 DM patients and patients refusing to participate). We enrolled 3027 smear-positive TB patients in the study, and excluded 219 participants; 173 patients were concomitantly infected with hepatitis or typhus, 38 participants were excluded due to missing HbA1c or anthropometric measurements, as well as eight participants who were HIV positive based on a rapid test. Thus, 2808 participants were included for analysis.
Most participants were born in Pakistan (97.9%), of whom 27.8% were from Lahore, 70.5% from other districts in Punjab, while only 1.7% had travelled to the hospital from other provinces in Pakistan.
Baseline characteristics of the study population
Of the 2808 participants enrolled, 64.4% were men (n = 1808) and the mean age of participants was 44.2 years (95% CI: 43.7; 44.7). Mean BMI was 19.0 kg/m 2 (95% CI: 18.8; 19.1), and mean WHR was 0.83 (95% CI, 0.82:0.83). Women were more likely to be obese (14.5% vs. 5.0%) and have a WC above central obesity cut-off value (37.6% vs. 3.5%). Mean HbA1c was 7.5% (95% CI: 7.4; 7.6) or 56.4 mmol/mol (95% CI: 55.4; 57.5). Only 30% of the participants had a haemoglobin value within normal range [20] , the remaining 70% were either mildly, moderately or severely anaemic. Illiteracy was common in our study population (63.5%) and only 2.0% had received 1-5 years of primary school education. The majority of female participants were housewives (86.0%) while most male participants had a non-sedentary occupation (blue collar) (73.1%).
Prevalence of DM among TB patients
The overall DM prevalence (known and screen-detected) was 39.6% among the newly diagnosed smear-positive TB patients. Excluding the patients with SDM, the prevalence of KDM remained high (26.1%). The prevalence of SDM was 13.5%, resulting in an additional yield of 34.2%. To find one new case of DM, 3.3 patients with TB needed to be screened. Furthermore, the prevalence of KDM was higher in women than men (30.3% vs. 23.7%, P < 0.001).
Comparison of the various TB groups (non-DM, SDM, KDM)
Results from the bivariate analyses for participants with and without DM are summarised in Table 1 . TB patients with DM were significantly older with higher WC, BMI blood pressure and haemoglobin values than TB patients without DM. Patients with DM were also more likely to have a family history of DM but less likely to smoke. Stratifying the DM group by SDM and KDM, these differences remained significant. The most common self-reported symptoms were loss of appetite, weight loss, cough and night sweats. There was no significant difference in the frequency of these symptoms between the three groups (results not shown). Participants with KDM were distinct from those with SDM in regard to anthropometrics; WHR and BMI were significantly higher in the KDM group than in the SDM group, though for WC in men only (Figure 2 (Figure 2) , and haemodynamic features (systolic and diastolic blood pressure). The OR of being overweight/obese was 6-8 times higher for participants with known DM than for TB participants without DM while the OR for the SDM group was four times higher (Table 2 ) than in the non-DM group. WC ≥ 90 cm for men and ≥80 cm for women in participants with KDM were both significantly associated with DM (OR 9.5 and 8.0, respectively), while OR of having a WC above the WHO cut-offs was approximately four times higher for the SDM group. Neuropathy (46.4%) and retinopathy (49.0%) were common complications in the KDM group.
Using regression analysis, HbA1c was positively associated with haemoglobin values, and this association remained significant when adjusted for age, sex and BMI across the three groups. A sensitivity analysis with and without the 39 individuals from the KDM group who had an HbA1c < 6.5%/48 mmol/mol and who did not receive DM treatment was carried out; no statistical significant differences were found in the between-group comparisons (results not shown).
Discussion
We report a very high prevalence of DM among patients with TB, which is compatible with similar observations in South Asia [21] [22] [23] . The prevalence of DM among patients with TB in our study was almost five times higher than the prevalence in the general population of Pakistan: 39.6% vs. 7.0% [7] and in Punjab 39.6.0% vs. 11.0% [9] (the prevalence for Punjab is a mean value of DM prevalence for males and females in the district). The higher DM prevalence among women in our study has not previously been reported in DM surveys from Pakistan, but a higher prevalence of overweight and obesity has been reported among Pakistani and South Asian women [24, 25] which was also the case in our study; three times more women than men were obese. The reasons why South Asian women are more affected by obesity than men remain unclear; however, South Asia is going through a rapid demographic (rural to urban migration), nutritional and economic changes leading to a more sedentary lifestyle and increased intake of fatty, refined carbohydrate and energy-dense foods. This transition is affecting all layers of society and not only the affluent social classes [26, 27] . The majority of women in our study were housewives confined to spending most of their time occupied with indoor housekeeping activities requiring little physical effort. Even though women were much more likely to be obese based on BMI cut-off, and central obesity based on WC cut-off, our observation should be interpreted with caution; this is based on the observations that women, at comparable levels of total adiposity, have lower levels of lipolysis-active intraabdominal/visceral fat than men [28] . The other main finding in our study was the anthropometric heterogeneity. Overall, in our TB population, BMI was highly diverse with a mean of 19.0 kg/m 2 (95% CI, 9.6; 55.5). Not surprisingly, based on BMI, patients with KDM were more obese, had a higher WC, hip and WHR than SDM and patients without DM, but the SDM group was also distinct from those without DM. Malnutrition is a risk factor for TB, but the relationship is bidirectional as TB infection itself causes wasting, and it is proposed that a normal or high BMI protects from TB and decreases mortality [29] [30] [31] . Previous studies have shown conflicting results; DM patients with TB were significantly more overweight in some but not in other studies [21, 32] . In our study, more TB patients with both known and screen-detected DM were obese than those without DM, and even though an optimal nutritional status and obesity may be a protective factor in TB, the altered immunity and hyperglycaemia possibly outweighs this advantage and may explain why there is an increased risk of TB treatment failure and mortality in patients with DM. Overweight/obesity may be used to identify TB patients with hyperglycaemia who could be at increased risk of developing manifest DM. Almost one-third of the patients with DM were overweight or obese and 20% of the women were centrally obese based on WC cut-off. This sex difference has previously been observed in other South Asian studies [23] . Whether women in this region are at particular risk of DM and obesity, and thereby also TB, is still uncertain, but based on our results, more focus on sex differences is warranted. Thus, DM has changed the symptomatology of TB; several studies have shown that DM patients with TB do not necessarily exhibit wasting, and the popular name of TB 'consumption' no longer applies. Severe underweight and malnutrition is usually treated by increasing the energy intake and supplements, but for some DM patients with obesity, the opposite might be advisable; however, it is important to bear in mind that obese patients with DM may be deficient in micronutrients [33] [34] [35] . Even though overweight and obesity were common among the patients with DM, 46.7% of the patients with SDM were underweight/extremely underweight, perhaps because their DM has not yet become chronic with obesity, or due to the fact that BMI in Asian patients with DM tends to be normal/low, maybe even lower than the WHO cut-offs for this ethnic group, which are based on East Asian and not South Asian individuals. Another aspect that has been discussed in relation to obese patients with TB is the possibility of treatment failure due to altered pharmacokinetics [36, 37] . The increased distribution volume may lead to decreased concentration of rifampicin requiring dosages to be increased according to bodyweight.
Among participants with KDM, 88 participants (8.3%) had an HbA1c < 6.5%/48 mmol/mmol. Of these, 39 participants did not receive antidiabetic treatment; most (85.0%) were normal, underweight or extreme underweight, which makes the previous DM diagnosis questionable. These 39 participants may have been diagnosed on a random blood sugar sample, a single fasting blood sugar or HbA1c not repeated to confirm the diagnosis; they could also have been tested for DM during concomitant disease resulting in temporary elevated blood sugar levels. The DM status of the remaining 49 patients with self-reported DM (KDM) who likewise had an HbA1c below 6.5% could also be questioned, despite this group receiving antidiabetic treatment. They were either very tightly regulated or had mild DM, but as only nine (18.3%) were treated with insulin, it would be unlikely to have normoglycaemia during a chronic infection.
It seems that 'transient' DM or hyperglycaemia is common among patients with TBs [5] , and newly diagnosed DM patients with TB should be followed up during TB treatment to confirm the DM diagnosis. As smear positive TB accounts for approximately 80% of transmission, we chose to screen participants with open pulmonary TB and found a small number needed to screen. Several studies have shown that transient hyperglycaemia is associated with increased mortality [38, 39] . Thus, in spite of the transient nature of non-DM hyperglycaemia, its detrimental effect on TB [6] underpins the importance of detecting hyperglycaemia in this high-risk population. Several studies from Asia have shown that screening is feasible and the National TB Control Programme in India has already implemented screening programmes [40, 41] . WHO also recommends that if the resources are available in regions with a high TB incidence, screening should be performed at the start of the treatment [42] . Asians not only develop DM but also related complications at an earlier age, which is why we chose to screen from 25 years of age, and even lower age limits have been set for screening programmes in other Asian studies [41, 43] . Almost one-third of the participants had moderate or severe anaemia which is not unusual for TB. HbA1c levels are overestimated in iron-deficient anaemic patients, but as HbA1c was positively correlated to haemoglobin levels in our study, an underestimation of the prevalence is possible, which only underlines the importance of screening for hyperglycaemia. Haemoglobinopathy traits such as b-thalassemias are common in South Asia [44] , and whether HbA1c should be the preferred as the diagnostic method in this region is uncertain. We acknowledge that HbA1c is expensive and not widely available in low-resource settings, but the method also has advantages: HbA1c is not affected by acute fluctuations in blood sugar levels, and does not require the patient to be fasting. However, fasting blood sugar is cheaper, and has in some studies been shown to be equally reliable [5] .
Conclusion
In conclusion, we found high prevalence of KDM as well as SDM in participants with TB. Furthermore, we found substantial anthropometric heterogeneity in KDM and SDM participants compared to those without DM. Even though this is the first large observational study from Pakistan, several studies from Asia have reported a high prevalence of DM in patients with TB, wherefore we, in line with the WHO policy, also recommend screening for DM if resources are available. This strategy should be implemented on a national level, and the Pakistan National TB Control Programme is advised to develop guidelines for an efficient integration of DM screening into the existing TB programmes. We used HbA1c for diagnosis, but fasting blood sugar and even random blood sugar testing has been used in large screening programmes in China [43] . Nevertheless, in newly diagnosed patients with DM, repeated blood sugar testing is recommended to rule out a false-positive result.
The changing clinical presentation of TB imposes new challenges for physicians as both diagnostic and therapeutic procedures have to be revised for this rapidly growing patient group. With an increased risk of developing TB and treatment failure, it is crucial to address the double burden of TB and DM in developing countries, especially if TB transmission is to be haltered and ultimately eliminated. An urgent need for a sustainable political commitment and allocation of more resources to health services is called for.
